Skip to main content

About Crohn’s and Colitis Australia

Formed in 1985, Crohn’s & Colitis Australia (CCA) is a non-profit organisation and the national peak body that represents approximately 80,000 Australians living with Crohn’s disease or ulcerative colitis, two chronic illnesses collectively known as inflammatory bowel disease (IBD). We aim to deliver services that inform, support, and care for people living with IBD in Australia and to promote research aimed at finding a cure.

CCA is the only organisation in Australia to provide these comprehensive services for patients and families. We work hard to raise awareness and educate the public, as well as collaborate closely with the medical profession and government to improve the quality of IBD patient care. Our staff are well equipped to help you understand your illness and connect you with others than can relate to your day to day challenges.

Visit our website https://www.crohnsandcolitis.com.au today.

The latest news and Research

News

Gutsy effort to produce comprehensive study of intestinal gases

Posted: September 18 2019

A source of embarrassment to some, or pure comedy to others, flatulence and the gases of the intestines are increasingly seen as playing an important role in our digestive health. A paper led by UNSW Sydney and published in Nature Reviews Gastroenterology & Hepatology has examined all available literature on gastrointestinal gases, their interactions with the microbiome […]

Read more

News

Putting an end to inflammation

Posted: September 18 2019

Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has succeeded in securing research funding in one of the toughest European selection processes. Over the next five years, the European Research Council (ERC) will support his outstanding research project with an ERC Starting Grant of 1.5 million euros. Dr. Andreas Ramming from the Department of Medicine […]

Read more

Research

Scientists discover promising new lead in Crohn’s disease

QIMR Berghofer researchers have identified a key driver of the aggressive gut disorder, Crohn’s disease, a finding that could eventually lead to new treatments for the often-debilitating condition.

Crohn’s disease – also known as inflammatory bowel disease – is incurable and affects about 35,000 people in Australia. QIMR Berghofer scientists found the protein PD-L2 was overactive in people with Crohn’s disease. The study was led by the head of the Molecular Immunology group, Dr Michelle Wykes, and Dr Graham Radford-Smith, who leads the […]

Read more

Personal Story

Student with stoma accused of taking drugs

Posted: September 11 2019

Amber Davies, 21, from Builth Wells, has a stoma after being diagnosed with ulcerative colitis aged 13. While on a night out in Birmingham, she was “grabbed” by a bouncer after coming out of the disabled toilet. Wetherspoons said staff apologised for the “confusing situation”. Amber posted an open letter on her Instagram account detailing her experience, saying the […]

Read more

Research

Diet-induced remission of Crohn’s disease associated with altered microbial community structure

Researchers from the University of Pennsylvania looked at the association of diet, gut microbiome and IBD.

Background The microbiome has been implicated in the initiation and persistence of inflammatory bowel disease. Despite the fact that diet is one of the most potent modulators of microbiome composition and function and that dietary intervention is the first-line therapy for treating pediatric Crohn’s disease, the relationships between diet-induced remission, enteropathy, and microbiome are poorly […]

Read more

News

Serotonin and anti-depressants can have a major effect on the gut’s microbiota

Posted: September 11 2019

Serotonin — a neurotransmitter, or chemical messenger that sends messages among cells — serves many functions in the human body, including playing a role in emotions and happiness. An estimated 90% of the body’s serotonin is produced in the gut, where it influences gut immunity. The team — led by senior author Elaine Hsiao and […]

Read more